3Barst RJ;Rubin LJ;Long WA.A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension[J],1996(05).
4Rubin LJ;Badesch DB;Barst RJ.Bosentan therapy for pulmonary arterial hypertension[J],2002(12).
5Sitbon O;Humbert M;Jais X.Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension[J],2005(23).
6Rubin LJ.Primary pulmonary hypertension[J]the New England Journal of Medicine,1997(02):111-117.
7Humbert M;Khaltaev N;Bousquet J.Pulmonary hypertension:from an orphan disease to a public health problem[J]Chest,2007(02):365-367.
8Galiè N;Hoeper MM;Humbert M.Guidelines for the diagnosis and treatment of pulmonary hypertension[J]European Heart Journal,2009(20):2493-2537.
9McLaughlin VV;Archer SL;Badesch DB.ACCF/ AHA 2009 Expert Consensus Document on Pulmonary Hypertension[J]Journal of the American College of Cardiology,2009(17):1573-1619.
10Simonneau G;Robbins IM;Beghetti M.Updated clinical classifi cation of pulmonary hypertension[J]Journal of the American College of Cardiology,2009(1 Suppl):S43-S54.
